• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Failure of a prothionamide-containing oral antituberculosis regimen.

作者信息

Langton M E, Cowie R L

出版信息

S Afr Med J. 1985 Dec 7;68(12):881.

PMID:4071346
Abstract

A group of 150 patients with sputum-positive pulmonary tuberculosis was treated with a regimen containing only orally administered drugs. Rifampicin and pyrazinamide were combined with Isoprodian, which contains isoniazid and also prothionamide and diaphenylsulphone. All the drugs were given daily for 5 months. Early analysis of the results shows 5 treatment failures, 27 relapses of pulmonary tuberculosis and another 17 patients who did not complete the prescribed regimen.

摘要

相似文献

1
Failure of a prothionamide-containing oral antituberculosis regimen.
S Afr Med J. 1985 Dec 7;68(12):881.
2
[Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
Prax Pneumol. 1976 Sep;30(9):584-7.
3
[Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].异烟肼与吡嗪酰胺以及异烟肼与利福平治疗肺结核的对比研究
Wien Med Wochenschr. 1982 Nov 30;132(22):559-61.
4
Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.采用异普罗地和利福平或吡嗪酰胺治疗的肺结核。
Chemotherapy. 1987;33(3):219-28. doi: 10.1159/000238498.
5
The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Lepr Rev. 1986;57 Suppl 3:29-37. doi: 10.5935/0305-7518.19860090.
6
[Clinical experience with isoprodian in the treatment of adult pulmonary tuberculosis (author's transl)].
Prax Pneumol. 1976 Apr;30(4):224-9.
7
Tolerability and efficacy of isoprodian-containing antituberculosis regimens.
S Afr Med J. 1986 Feb 1;69(3):161.
8
The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Lepr Rev. 1986;57 Suppl 3:63-6. doi: 10.5935/0305-7518.19860096.
9
[Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
Prax Pneumol. 1977 Feb;31(2):116-20.
10
First assessment of the Malta Leprosy Eradication Project.
Lepr Rev. 1986;57 Suppl 3:42-6. doi: 10.5935/0305-7518.19860092.

引用本文的文献

1
Expression Profile of Markers of Apoptosis, Injury and Oxidative Stress in Human Lung Epithelium Cells-A5449 Receiving Chronic Exposure of Potential Anti-Tubercular Drug-trans-Cyclohexane-1, 4-Diamine Derivative-"9u".人肺上皮细胞-A5449长期暴露于潜在抗结核药物反式环己烷-1,4-二胺衍生物-“9u”后凋亡、损伤和氧化应激标志物的表达谱
Toxicol Int. 2014 May;21(2):172-8. doi: 10.4103/0971-6580.139803.
2
Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity.可吸入微粒增强结核分枝杆菌感染的THP-1细胞凋亡及其与杀菌活性的相关性
Antimicrob Agents Chemother. 2007 Oct;51(10):3740-2. doi: 10.1128/AAC.00925-07. Epub 2007 Jul 30.